Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Irinotecan plus Paclitaxel in Advanced NSCLC
NCT00004924Phase 2Completed
- Sponsor
- Yale University
- Start
- Mar 1999
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of irinotecan, paclitaxel in non-small cell lung cancer (NSCLC), sponsored by Yale University. Started Mar 1999; status: completed.
02
Drugs
irinotecanpaclitaxel
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00004924.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00004924.